Long Term (1 Year) Respiratory Sequelae in Children Surviving an Acute Respiratory Distress Syndrome

Sponsor
University Hospital, Lille (Other)
Overall Status
Completed
CT.gov ID
NCT01435889
Collaborator
(none)
38
5
100
7.6
0.1

Study Details

Study Description

Brief Summary

The purpose of this study is to assess long term (1 year) respiratory sequelae in children surviving an acute respiratory distress syndrome

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The acute respiratory distress syndrome (ARDS) has a high mortality rate in children. Adverse long term sequelae, and in particular respiratory sequelae, have been described mainly in adults. Decrease in diffusing capacity, lung volume and exercise tolerance were observed. Lung function parameters improve during the follow-up until 6 month after discharge from the pediatric intensive care unit (PICU). After that, abnormalities in PFT are observed in a significant proportion of patients. Only two studies described long-term sequelae in children surviving to an ARDS and their results are conflicting. Two studies carried out in adults described the morphologic long-term sequelae by thoracic computed tomography. They showed reticular pattern with a striking anterior distribution in most patients evaluated more than 6 months after discharge from the PICU. There is, to our knowledge, no study describing morphologic pulmonary sequelae by thoracic computed tomography in children surviving to ARDS.

    Respiratory assessment: respiratory sequelae in children surviving to the acute respiratory distress syndrome will be evaluated 1 year after discharge from the PICU. Assessment will include a clinical evaluation (respiratory history and physical examination), respiratory function tests and thoracic computed tomography

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    38 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Long Term (1 Year) Respiratory Sequelae in Children Surviving Acute Respiratory Distress Syndrome
    Study Start Date :
    Jun 1, 2006
    Actual Primary Completion Date :
    Oct 1, 2014
    Actual Study Completion Date :
    Oct 1, 2014

    Outcome Measures

    Primary Outcome Measures

    1. Dynamic lung compliance [1 year +- 2 months after discharge from ICU]

    Secondary Outcome Measures

    1. respiratory complaints (cough, wheeze,dypnea at rest on exertion, bronchitis, pneumonia [1 year +- 2 months after discharge from ICU]

    2. extend of ground glass opacification (CT scan) [1 year +- 2 months after discharge from ICU]

    3. extend of intense parenchymal opacification [1 year +- 2 months after discharge from ICU]

    4. extend of reticular pattern [1 year +- 2 months after discharge from ICU]

    5. extend of decreased attenuation due to emphysema [1 year +- 2 months after discharge from ICU]

    6. extend of decreased attenuation attributable to small-airway disease [1 year +- 2 months after discharge from ICU]

    7. carbon monoxide diffusing capacity [1 year +- 2 months after discharge from ICU]

    8. Pulse oxymetry oxygen saturation at the end of a 6 min walk test [1 year +- 2 months after discharge from ICU]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Year to 16 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • children surviving to an acute respiratory distress syndrome and alive 1 year after discharge from the PICU
    Exclusion Criteria:
    • children suffering from neuromuscular disease

    • children presenting symptoms of chronic respiratory disease before ARDS

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels Belgium 1020
    2 Hôpital Jeanne de Flandre, Centre Hospitalier Régional et Universitaire de Lille Lille France 59 037 Lille Cedex
    3 Hôpital Trousseau, Assistance Publique Hôpitaux de Paris Paris France 75 571 Paris Cedex 12
    4 Hôpital Robert Debré, Assistance Publique Hôpitaux de Paris Paris France 75 935 Cedex 19
    5 Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris Paris France 75743 Paris Cedex 19

    Sponsors and Collaborators

    • University Hospital, Lille

    Investigators

    • Study Chair: Francis Leclerc, MD, University hospital of Lille , France

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Lille
    ClinicalTrials.gov Identifier:
    NCT01435889
    Other Study ID Numbers:
    • PHRC 2005/R-1906
    • PHRC 2005/R-1906
    First Posted:
    Sep 19, 2011
    Last Update Posted:
    Dec 2, 2015
    Last Verified:
    Dec 1, 2015

    Study Results

    No Results Posted as of Dec 2, 2015